Strategy interview with Philippe Roussouly, CEO of Smaio. The company specializing in spine surgery is launching an IPO for at least €9 million on Euronext Growth. Driven by Nuvasive, its new American partner, the family-owned company is forging ahead despite the difficult context for financing its growth. Objective: 12 million euros...
"We intervene before, during and after surgery"

Philippe Roussouly (Smaio): "I think robotics will take an increasing place in operating rooms in the next 5 to 10 years."